NLS Pharmaceutics AG logo
NLS Pharmaceutics AG NLSP

Quarterly report 2025-Q4
added 05-27-2026

report update icon

NLS Pharmaceutics AG ROCE Ratio 2011-2026 | NLSP

Annual ROCE Ratio NLS Pharmaceutics AG

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-35.34 25.84 251.88 -13948.08 -2186.74 38.37 125.71 151.99 - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
251.88 -13948.08 -1947.05

Quarterly ROCE Ratio NLS Pharmaceutics AG

2025-Q4 2025-Q2 2024-Q4 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-63.65 223.57 475.98 22.16 251.88 - 176.11 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
475.98 -63.65 181.01